Pharma Veterans

Pharma & the Future: Powered by Partnership & Patient Experience – Asrar Qureshi’s Blog Post 993 Dear Colleagues! This is Asrar Qureshi’s Blog Post 993 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to aq.pharmaveterans@gmail.com for publishing your contributions here. Image Created with Microsoft Designer Image Created with Microsoft Designer Image Created with Microsoft Designer This blogpost is a summary of the new White-paper on the subject of patients’ engagement with Pharma Industry. Link at the end. [Quote] Pharma has long been guilty of putting profit before people, but that's beginning to change. While there's still a long road ahead, patient-engagement efforts are steadily improving. [Unquote]. Pharma & Patient USA 2024 shall be held on October 15-16, 2024 at Westin Boston Seaport. The event is organized by Reuters. Preamble The pharmaceutical industry is undergoing a...

Pharma Industry and Doctors – Asrar Qureshi’s Blog Post #699 Dear Colleagues!  This is Asrar Qureshi’s Blog Post #699 for Pharma Veterans. Pharma Veterans welcome sharing of knowledge and wisdom by Veterans for the benefit of Community at large. Pharma Veterans Blog is published by Asrar Qureshi on  WordPress, the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here. Photo Credit: Alena Darmel Photo Credit: Antoni Shkraba Photo Credit: Karolina Gabrowska This series of posts gives ideas about what opportunities new graduates can find in pharmaceutical industry. Pharmaceutical Industry is a large industry; it employs a fair number of people in various departments.  Doctors Doctors have long been associated with Pharma Industry. Several of them started their own pharmaceutical industries internationally, and in Pakistan; but they are not our focus in this post. We shall focus on the opportunities that become available to doctors. Like...

  License for Hemp Use; A Bold Decision II – Blog Post #377 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #377. Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   Continued from Previous…… While medical research is making big strides in the field of Cannabis, the acceptance and legalization is not as universal. The first countries legalizing Cannabis for medical use were Canada and Uruguay. Uruguay is also the first country to legalize Cannabis for recreational use. Center for Medicinal Cannabis Research ( https://www.cmcr.ucsd.edu ) is based in the University of California, San Diego and is coordinating research on Cannabis. In 1999, California State legislated and commissioned University of California to es...

The REMDESIVIR Trials – Blog Post #347 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #347 . Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here .   Remdesivir is a broad-spectrum antiviral compound developed by Gilead Sciences USA. It is to be given by injection into a vein. The initial studies identified activity against several RNA viruses, however, Remdesivir was not approved for any indication. Remdesivir was originally developed to treat Hepatitis C where Gilead already had great victories with Sofosbuvir and combinations. It was also tested against Ebola virus and Marburg virus disease but was found to be ineffective against all of these. Lately, Remdesivir has been tried in COVID19 in several trials. Here is how ...

Data Fraud in Medical Research  - Part I – Blog Post #323 by Asrar Qureshi Dear Colleagues!  This is Pharma Veterans Blog Post #323 . Pharma Veterans welcomes sharing of knowledge and wisdom by Veterans for the benefit of Community at large . Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. Please email to asrar@asrarqureshi.com for publishing your contributions here . Clin Investig (Lond). 2015; 5(2): 161–173. doi:  10.4155/cli.14.116   Authors. Stephen L George *,1  and  Marc Buyse 2 [Quote] “ Highly publicized cases of fabrication or falsification of data in clinical trials have occurred in recent years and it is likely that there are additional undetected or unreported cases. We review the available evidence on the incidence of data fraud in clinical trials, describe several prominent cases, present information on motivation and contributing factors and discuss cost-effective ways...

Dear Colleagues!  This is Pharma Veterans Blog Post #219. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of Pharma Community. Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site. If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . PHARMA INDUSTRY – Putting it in Perspective My recently concluded 30-part series on Pharma business in Pakistan captured the spectrum of functions, processes and activities associated with Pharma business. This post will cover the relevance and importance of Pharma industry. It is not just about Pakistan; it is about every country. World Pharma market has crossed one trillion US$ annually. About 44% is North America alone; rest is rest of the world. Pakistan is around 2.8 billion US$ for comparison. 1.      Healthcare Aspect – Going by th...